<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02668614</url>
  </required_header>
  <id_info>
    <org_study_id>HSREB 107218</org_study_id>
    <nct_id>NCT02668614</nct_id>
  </id_info>
  <brief_title>Early Detection of Skin Cancer With Sensor Technology</brief_title>
  <official_title>Early Detection of Skin Cancer Using Millimetre-Wave Waveguide Reflectometers</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Lawson Health Research Institute</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Lawson Health Research Institute</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Skin cancer represents a large problem in today's healthcare setting. The majority of cancer
      diagnoses are attributed to malignant skin diseases including its major types: basal cell
      carcinoma, squamous cell carcinoma and melanoma. Early diagnoses is critical given early
      detection of malignant lesions largely increases chances of successful treatment. The current
      gold standard of diagnosis is histopathological examination of biopsied skin. Biopsies are
      not only invasive and expensive, they have variable positive predictive value, meaning they
      may often be preformed unnecessarily. As such, the investigators have developed a skin
      scanner, which is less bulky and expensive than existing similar technologies, as a tool to
      evaluate skin lesions prior to determining the need for a biopsy. Their objective is to
      obtain information in order to validate this skin scanner in the context of its ability to
      accurately identify basal cell carcinoma skin lesions.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">February 2016</start_date>
  <completion_date type="Actual">February 2018</completion_date>
  <primary_completion_date type="Actual">February 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Positive predictive value</measure>
    <time_frame>Immediately pre-biopsy</time_frame>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">60</enrollment>
  <condition>Carcinoma, Basal Cell</condition>
  <arm_group>
    <arm_group_label>WR-22 model microwave sensor</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>WR-22 model microwave sensor</intervention_name>
    <arm_group_label>WR-22 model microwave sensor</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patient requiring skin biopsy for suspected basal cell carcinoma skin lesion

          -  18 years of age or older

        Exclusion Criteria:

        -Poor english fluency, Pregnancy
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <verification_date>November 2018</verification_date>
  <study_first_submitted>January 26, 2016</study_first_submitted>
  <study_first_submitted_qc>January 26, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 29, 2016</study_first_posted>
  <last_update_submitted>November 2, 2018</last_update_submitted>
  <last_update_submitted_qc>November 2, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">November 6, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Detection</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Skin Neoplasms</mesh_term>
    <mesh_term>Carcinoma, Basal Cell</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

